Inovio Pharmaceuticals, Inc. (INO) stock
INONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.63+0.23 (+16.43%)
Close on Nov 17, 2026Market cap $168.54MP/E –Yield –
Inovio Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Inovio Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2025 was -130000.0%. For fiscal 2025 it was -130000.0%, against -49254.3% the year before. The highest annual figure on record is -71.9% in fiscal 2015.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -130000.0% | −80745.7 |
| FY2024 | Dec 31, 2024 | -49254.3% | −33014.4 |
| FY2023 | Dec 31, 2023 | -16239.9% | −13513.2 |
| FY2022 | Dec 31, 2022 | -2726.7% | +14383.2 |
| FY2021 | Dec 31, 2021 | -17109.9% | −14864.5 |
| FY2020 | Dec 31, 2020 | -2245.4% | +657.4 |
| FY2019 | Dec 31, 2019 | -2902.8% | −2584.6 |
| FY2018 | Dec 31, 2018 | -318.1% | −109.2 |
| FY2017 | Dec 31, 2017 | -208.9% | −0.4 |
| FY2016 | Dec 31, 2016 | -208.5% | −136.6 |
| FY2015 | Dec 31, 2015 | -71.9% | +273.5 |
| FY2014 | Dec 31, 2014 | -345.4% | +144.8 |
| FY2013 | Dec 31, 2013 | -490.3% | −12.7 |
| FY2012 | Dec 31, 2012 | -477.6% | −321.8 |
| FY2011 | Dec 31, 2011 | -155.7% | +130.9 |
| FY2010 | Dec 31, 2010 | -286.6% | −19.0 |
| FY2009 | Dec 31, 2009 | -267.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -30140.5% | −21405.7 |
| Q4 FY2024 | Dec 31, 2024 | -16566.4% | −841.1 |
| Q2 FY2024 | Jun 30, 2024 | -31993.3% | +3371.5 |
| Q4 FY2023 | Dec 31, 2023 | -24357.9% | +19329.3 |
| Q3 FY2023 | Sep 30, 2023 | -8734.8% | −8322.0 |
| Q2 FY2023 | Jun 30, 2023 | -15725.3% | −1893.3 |
| Q1 FY2023 | Mar 31, 2023 | -35364.8% | +4356.0 |
| Q4 FY2022 | Dec 31, 2022 | -43687.2% | −30942.0 |
| Q3 FY2022 | Sep 30, 2022 | -412.8% | +20214.4 |
| Q2 FY2022 | Jun 30, 2022 | -13832.0% | +16275.3 |
| Q1 FY2022 | Mar 31, 2022 | -39720.8% | −25061.9 |
| Q4 FY2021 | Dec 31, 2021 | -12745.3% | −12309.2 |
| Q3 FY2021 | Sep 30, 2021 | -20627.2% | −28744.5 |
| Q2 FY2021 | Jun 30, 2021 | -30107.3% | +18062.3 |
| Q1 FY2021 | Mar 31, 2021 | -14658.9% | −12207.2 |
| Q4 FY2020 | Dec 31, 2020 | -436.1% | +13039.2 |
| Q3 FY2020 | Sep 30, 2020 | 8117.3% | +10781.0 |
| Q2 FY2020 | Jun 30, 2020 | -48169.7% | −26509.3 |
| Q1 FY2020 | Mar 31, 2020 | -2451.7% | −1419.2 |
| Q4 FY2019 | Dec 31, 2019 | -13475.4% | −12158.3 |
| Q3 FY2019 | Sep 30, 2019 | -2663.7% | −1413.5 |
| Q2 FY2019 | Jun 30, 2019 | -21660.3% | −21633.2 |
| Q1 FY2019 | Mar 31, 2019 | -1032.5% | +1082.4 |
| Q4 FY2018 | Dec 31, 2018 | -1317.1% | −1072.4 |
| Q3 FY2018 | Sep 30, 2018 | -1250.2% | +40.5 |
| Q2 FY2018 | Jun 30, 2018 | -27.2% | +19.3 |
| Q1 FY2018 | Mar 31, 2018 | -2114.9% | −1892.4 |
| Q4 FY2017 | Dec 31, 2017 | -244.7% | +63.4 |
| Q3 FY2017 | Sep 30, 2017 | -1290.8% | −1125.2 |
| Q2 FY2017 | Jun 30, 2017 | -46.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -222.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -308.1% | – |
| Q3 FY2016 | Sep 30, 2016 | -165.5% | – |
See a number that looks wrong?